A Randomized Comparison of High Clopidogrel Loading Doses in Patients With NonST-Segment Elevation Acute Coronary Syndromes
The ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) Trial
Gilles Montalescot, MD, PhD*,*,
Georges Sideris, MD ,
Catherine Meuleman, MD ,
Claire Bal-dit-Sollier, MB ,
Nicolas Lellouche, MD||,
Ph. Gabriel Steg, MD¶,
Michel Slama, MD#,
Olivier Milleron, MD**,
Jean-Philippe Collet, MD, PhD*,
Patrick Henry, MD ,
Farzin Beygui, MD, PhD*,
Ludovic Drouet, MD, PhD for the ALBION Trial Investigators
* Institut de CardiologiePitié-Salpêtriére University Hospital, Assistence Publique Hôpiteux de Paris (APHP)
Service de CardiologieLariboisiére University Hospital, APHP
Service de CardiologieSaint-Antoine University Hospital, APHP
Laboratoire d'HémostaseLariboisière University Hospital, APHP
|| Service de CardiologieHenri-Mondor University Hospital, APHP
¶ Service de CardiologieHôpital Bichat-Claude Bernard, APHP
# Service de CardiologieAntoine Béclère University Hospital, APHP
** Service de CardiologieAmbroise Paré University Hospital, APHP, Paris, France

View larger version (24K):
[in a new window]
|
Figure 1 (A) Percentage inhibition of platelet aggregation after stimulation with 5 µmol/l adenosine diphosphate (ADP). (B) Percentage inhibition of platelet aggregation after stimulation with 20 µmol/l ADP.
|
|

View larger version (26K):
[in a new window]
|
Figure 2 Areas under the curves for inhibition of adenosine diphosphate (ADP)-induced platelet aggregation between 0 and 24 h. Error bars indicate standard deviations of the mean. AUC = area under the IPA curve.
|
|

View larger version (25K):
[in a new window]
|
Figure 3 (Left) Mean fluorescence intensity (MFI) after the coadministration of PGE1 and adenosine diphosphate (ADP) at 6 h after dosing. (Right) Vasodilator-stimulated phosphoprotein (VASP) index at 6 h after dosing. Error bars indicate standard deviations of the mean.
|
|

View larger version (32K):
[in a new window]
|
Figure 4 Proportion of patients with increased troponin over the course of 24 h.
|
|
|